43 employees
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
2008
$60M
from 3 investors over 3 rounds
Trevena, Inc. raised $35M on September 22, 2014
Investors: Oxford Finance LLC and Square 1 Bank
Trevena, Inc. raised $60M on May 9, 2013
Investors: Forest Laboratories